Nerima-ku, Japan

Minpei Kuroda


Average Co-Inventor Count = 8.7

ph-index = 2

Forward Citations = 23(Granted Patents)


Location History:

  • Tokyo, JP (2006)
  • Nerima-ku, JP (2009 - 2011)

Company Filing History:


Years Active: 2006-2011

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Minpei Kuroda: Innovator in Pharmaceutical Compounds

Introduction

Minpei Kuroda is a notable inventor based in Nerima-ku, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target insulin resistance. With a total of four patents to his name, Kuroda's work is recognized for its innovative approach to health-related issues.

Latest Patents

Kuroda's latest patents include a peroxisome proliferator-activated receptor ligand and a process for producing the same. This invention provides an efficient method for creating a ligand that can ameliorate insulin resistance or prevent the insulin resistance syndrome. The ligand comprises various components, including prenylflavonoids and chalcone derivatives, which are essential for its pharmaceutical applications. Another significant patent involves novel compounds extracted from plants in the Compositae family, showcasing Kuroda's dedication to natural product research.

Career Highlights

Throughout his career, Kuroda has worked with prominent companies such as Kaneka Corporation and Hiro International Co., Ltd. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in the pharmaceutical industry.

Collaborations

Kuroda has collaborated with esteemed colleagues, including Yoshihiro Mimaki and Yutaka Sashida. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to the development of impactful inventions.

Conclusion

Minpei Kuroda's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in treatments for insulin resistance and related health issues.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…